Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.

J Clin Med · 2019 · PMC6833062 · PMID 31546720

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Finally, as low adherence to treatment drugs such as hydroxyurea taken throughout life is frequent in SCD patients, the highly significant improvement of HRQL post-SCT should be stressed to patients, parents and caregivers, which might help them to decide on HSCT that can cure the disease.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.